Subscribe to RSS
DOI: 10.1055/s-0028-1087915
An Efficient, Regioselective, Versatile Synthesis of N-Fused 2- and 3-Aminoimidazoles via Ugi-Type Multicomponent Reaction Mediated by Zirconium(IV) Chloride in Polyethylene Glycol-400
Publication History
Publication Date:
16 February 2009 (online)
Abstract
An Ugi-type multicomponent reaction of heterocyclic amidines with aldehydes and isocyanides catalyzed by zirconium(IV) chloride in PEG-400 was developed. The protocol offers the rapid, environment friendly, regioselective and versatile synthesis of medicinally important N-fused 2- and 3-aminoimidazoles in good to high yields. The combination of catalyst and solvent, that was judiciously explored, was crucial for regioselectivity and versatility of the method.
Key words
multicomponent reaction - regioselective synthesis - N-heterocycles - zirconium(IV) chloride - polyethylene glycol
-
1a
Budriesi R.Ioan P.Locatelli A.Cosconati S.Leoni A.Ugenti MP.Andreani A.Di Toro R.Bedini A.Spampinato S.Marinelli L.Novellino E.Chiarini A.
J. Med. Chem. 2008, 51: 1592 -
1b
Fookes CJR.Pham TQ.Mattner F.Greguric I.Loc’h C.Liu X.Berghofer P.Shepherd R.Gregoire M.-C.Katsifis A.
J. Med. Chem. 2008, 51: 3700 -
1c
Jin Z. Nat. Prod. Rep. 2005, 22: 196 - 2
Rival Y.Grassy G.Michel G. Chem. Pharm. Bull. 1992, 40: 1170 -
3a
Hamdouchi C.de Blas J.del Prado M.Gruber J.Heinz BA.Vance L. J. Med. Chem. 1999, 42: 50 -
3b
Lhassani M.Chavignon O.Chezal J.-M.Teulade J.-C.Chapat J.-P.Snoeck R.Andrei G.Balzarini J.De Clercq E.Gueiffier A. J. Med. Chem. 1999, 34: 271 -
4a
Fisher MH.Lusi A. J. Med. Chem. 1972, 15: 982 -
4b
Rival Y.Grassy G.Taudou A.Ecalle R. Eur. J. Med. Chem. 1991, 26: 13 - 5
Rupert KC.Henry JR.Dodd JH.Wadsworth SA.Cavender DE.Olini GC.Fahmy B.Siekierka JJ. Bioorg. Med. Chem. Lett. 2003, 13: 347 - 6
Hamdouchi C.Zhong B.Mendoza J.Collins E.Jaramillo C.De Diego JE.Robertson D.Spencer CD.Anderson BD.Watkins SA.Zhang F.Brooks HB. Bioorg. Med. Chem. Lett. 2005, 15: 1943 - 7
Goodacre SC.Street LJ.Hallett DJ.Crawforth JM.Kelly S.Owens AP.Blackaby WP.Lewis RT.Stanley J.Smith AJ.Ferris P.Sohal B.Cook SM.Pike A.Brown N.Wafford KA.Marshall G.Castro JL.Atack JR. J. Med. Chem. 2006, 49: 35 - 8
Abe Y.Kayakiri H.Satoh S.Inoue T.Sawada Y.Imai K.Inamura N.Asano M.Hatori C.Katayama A.Oku T.Tanaka H. J. Med. Chem. 1998, 41: 564 - 9
Sanfilippo PJ.Urbanski M.Press JB.Dubinsky B.Moore JB. J. Med. Chem. 1988, 31: 2221 -
10a
Koubachi J.El Kazzouli S.Berteina-Raboin S.Mouaddib A.Guillaumet G. J. Org. Chem. 2007, 72: 7650 -
10b
Imaeda Y.Kawamoto T.Tobisu M.Konishi N.Hiroe K.Kawamura M.Tanaka T.Kubo K. Bioorg. Med. Chem. 2008, 16: 3125 - 11
Katritzky AR.Xu Y.-J.Tu H. J. Org. Chem. 2003, 68: 4935 -
12a
Bienayme H.Bouzid K. Angew. Chem. Int. Ed. 1998, 37: 2234 -
12b
Blackburn C.Guan B.Fleming P.Shiosaki K.Tsai S. Tetrahedron Lett. 1998, 39: 3635 -
12c
Groebke K.Weber L.Mehlin F. Synlett 1998, 661 -
12d
DiMauro EF.Kennedy JM. J. Org. Chem. 2007, 72: 1013 -
12e
Parchinsky VZ.Shuvalova O.Ushakova O.Kravchenko DV.Krasavin M. Tetrahedron Lett. 2006, 47: 947 -
12f
Mandair GS.Light M.Russell A.Hursthouse M.Bradley M. Tetrahedron Lett. 2002, 43: 4267 -
12g
Rousseau AL.Matlaba P.Parkinson CJ. Tetrahedron Lett. 2007, 48: 4079 -
12h
Ireland SM.Tye H.Whittaker M. Tetrahedron Lett. 2003, 44: 4369 -
12i
Varma RS.Kumar D. Tetrahedron Lett. 1999, 40: 7665 -
12j
Chen JJ.Golebiowski A.McClenaghan J.Klopfenstein SR.West L. Tetrahedron Lett. 2001, 42: 2269 -
12k
Blackburn C. Tetrahedron Lett. 1998, 39: 5469 - 13
Parenty ADC.Song Y.-F.Richmond CJ.Cronin L. Org. Lett. 2007, 9: 2253 - 14
Bakherad M.Nasr-Isfahani H.Keivanloo A.Doostmohammadi N. Tetrahedron Lett. 2008, 49: 3819 - 15
Dömling A. Chem. Rev. 2006, 106: 17 - For greener use of PEG-400 as solvent, see:
-
16a
Han W.Liu C.Jin Z.-L. Org. Lett. 2007, 9: 4005 -
16b
Kouznetsov VV.Merchan Arenas DR.Romero Bohórquez AR. Tetrahedron Lett. 2008, 49: 3097 ; and references cited therein -
17a For
significant use of ZrCl4, see: Review paper:
Smitha G.Chandrasekhar S.Reddy CS. Synthesis 2008, 829 -
17b
Bhagat S.Chakraborti AK. J. Org. Chem. 2008, 73: 6029 -
17c
Chakraborti AK.Kondaskar A. Tetrahedron Lett. 2003, 44: 8315 - 19
Lyon MA.Kercher TS. Org. Lett. 2004, 6: 4989 - 20
Blackburn C.Guan B. Tetrahedron Lett. 2000, 41: 1495
References and Notes
Representative
Experimental Procedure for the Synthesis of N
-
tert
-Butyl-2-(4-chlorophenyl)imidazo[1,2-
a
]pyridin-3-amine
(Table 2, entry 1): To a mixture of 2-aminopyridine (0.19 g,
2 mmol) and 4-chlorobenzaldehyde (0.28 g, 2 mmol) in PEG-400 (2
mL), tert-butyl isocyanide (0.17 g, 2
mmol) and ZrCl4 (47 mg, 10 mol%) were added. The
mixture was allowed to stir at 50 ˚C under open air. After
completion of the reaction (4.5 h, monitored by TLC), the resulting
mixture was extracted with EtOAc and washed with H2O.
The organic layer was dried over anhyd Na2SO4, filtered
and concentrated under reduced pressure. The column chromatographic
purification of crude product over silica gel (mesh size: 60-120)
eluting with EtOAc-hexane (1:1.5) afforded N-tert-butyl-2-(4-chlorophenyl)imidazo-[1,2-a]pyridin-3-amine (0.48 g, 85%);
white solid; mp 146-149 ˚C. MS (ESI): m/z = 300 [M + 1]. ¹H
NMR (400 MHz, CDCl3): δ = 1.06 (s,
9 H), 3.00 (br, NH), 6.78 (t, J = 6.8
Hz, 1 H), 7.15 (t, J = 8.0 Hz,
1 H), 7.40 (d, J = 8.8 Hz, 2
H), 7.54 (d, J = 7.2 Hz, 1 H),
7.92 (d, J = 8.8 Hz, 1 H), 8.20
(d, J = 6.8 Hz, 1 H). ¹³C
NMR (100 MHz, CDCl3): δ = 30.3 (3 × Me), 56.4
(C), 111.5 (CH), 117.3 (CH), 123.3 (CH), 123.4 (C), 124.3 (CH),
128.4 (2 × CH), 129.3 (2 × CH), 133.1 (C), 133.7
(C), 138.3 (C), 142.0 (C). IR (KBr): 3457, 2972, 1635, 1194, 770
cm-¹. Anal. Calcd for C17H18ClN3:
C, 68.11; H, 6.05; N, 14.02. Found: C, 67.89; H, 6.07; N, 13.99.
All
reactions (Tables
[¹]
-
[³]
) were carried out following
this procedure.